- /
- Supported exchanges
- / US
- / AEMD.NASDAQ
Aethlon Medical Inc (AEMD NASDAQ) stock market data APIs
Aethlon Medical Inc Financial Data Overview
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Aethlon Medical Inc data using free add-ons & libraries
Get Aethlon Medical Inc Fundamental Data
Aethlon Medical Inc Fundamental data includes:
- Net Revenue: 574 K
- EBITDA: -7 007 023
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-13
- EPS/Forecast: -2.01
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Aethlon Medical Inc News
New
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Inves...
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Virtual Investor Conferences NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the...
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
Virtual Investor Conferences Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Virtual Investor ...
Aethlon Medical signals faster clinical trial enrollment amid Hemopurifier advancements
Earnings Call Insights: Aethlon Medical (AEMD) Q3 2026 MANAGEMENT VIEW * James Frakes, CEO and CFO, stated that Aethlon Medical continues to execute its strategy of advancing the Hemopurifier plat...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.